Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration
IntroductionElevated calcium (Ca2+) levels and hyperactivation of the Ca2+-dependent phosphatase calcineurin are key factors in α-synuclein (α-syn) pathobiology in Dementia with Lewy Bodies and Parkinson’s Disease (PD). Calcineurin activity can be inhibited by FK506, an FDA-approved compound. Our pr...
Saved in:
| Main Authors: | Ekaterina Grebenik, Sofia Zaichick, Gabriela Caraveo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Aging Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2025.1566465/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus
by: Eliane Vanhoffelen, et al.
Published: (2025-04-01) -
The Immunosuppressant Tacrolimus (FK506) Facing the 21st Century: Past Findings, Present Applications and Future Trends
by: Carlos Barreiro, et al.
Published: (2024-12-01) -
Efficacy of cold and cryo-preserved nerve allografts with low-dose FK506 for motor nerve regeneration: a preclinical study
by: Jong Pil Kim, et al.
Published: (2024-12-01) -
Impact of CYP3A4 and ABCB1 genetic variants on tacrolimus dosing in Greek kidney transplant recipients
by: Anna Tsironi, et al.
Published: (2025-03-01) -
Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
by: Wada A, et al.
Published: (2016-07-01)